SCHEMBL5720972

SCHEMBL5720972

N[C@H](CC(=O)O)c1ccccc1I

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 1/20 0.42
GABBR1 Q9UBS5 1/20 0.42
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP2C19 P33261 3/20 0.39
CYP1A2 P05177 3/20 0.38
TSHR P16473 2/20 0.38
CPA1 P15085 2/20 0.38
CPB1 P15086 1/20 0.38
CPA3 P15088 1/20 0.38
CPB2 Q96IY4 1/20 0.38
CYP2C9 P11712 2/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
ALPI P09923 1/20 0.36
PKM P14618 1/20 0.36
PTGS1 P23219 1/20 0.36
XIAP P98170 1/20 0.36
SLC7A5 Q01650 1/20 0.36
CTSA P10619 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720977 1.00 GABBR2 (0.42) GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19
SCHEMBL2320833 0.79 CTSA (0.47) GABBR2GABBR1CTSA
SCHEMBL5597477 0.79 AKR1B1 (0.44) GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19
SCHEMBL2320843 0.79 CTSA (0.47) GABBR2GABBR1CTSA
SCHEMBL31757740 0.79 AKR1B1 (0.44) GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19
SCHEMBL5918770 0.79 AKR1B1 (0.44) GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19
SCHEMBL5720952 0.79 CTSA (0.47) GABBR2GABBR1CTSA
SCHEMBL29249378 0.79 CYP1A2 (0.39) GABBR2GABBR1SMN1; SMN2CYP2C19CYP1A2
SCHEMBL25253132 0.78 CTSA (0.47) GABBR2GABBR1KMT2ACTSA
Hydrochloric Acid SCHEMBL6947309 0.78 AKR1B1 (0.42) GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060178433-A1 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto UBE INDUSTRIES, LTD. (JP) 2006-08-10 US disclosed
EP-1621529-A1 3-AMINO-3-ARYLPROPIONIC ACID n-ALKYL ESTERS, PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE 3-AMINO-3-ARYLPROPIONIC ACIDS AND ESTERS OF THE ANTIPODES THERETO Ube Industries, Ltd. (JP) 2006-02-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060178433-A1 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto ALAD, ARSA, ALDH7A1 GABBR2 274/4885GABBR1 127/4885KMT2A 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.